Heel Incision Devices Market Growth Drivers and Restrain Factors Study Report | BD, Owen Mumford Ltd., Cardinal Health, Smiths Medical

Heel Incision Devices Market: Introduction

According to the report, the global heel incision devices market was valued at ~US$ 174 Mn in 2019. The heel incision devices market is projected to expand at a CAGR of ~3% from 2020 to 2030. Blood samples from infants can be obtained from either an indwelling catheter or a heel puncture. Puncturing a newborn's heel for blood collection is a crucial step in the process of detecting potentially fatal, congenital diseases. Heel incision devices are safe, gentle, and effective to collect blood from babies. Heel incision device provides a precise incision for adequate blood sampling with less re-sticking. Heel incision devices are available for newborn, preemie, micro-preemie, and toddler. North America dominated the global heel incision devices market in 2019. The trend is anticipated to continue during the forecast period. Mandatory newborn screening under the Newborn Screening Saves Lives Act of 2007 across North America propels the demand for heel incision devices.

Download Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79383

Mandatory Newborn Testing Policy Adopted in Several Countries to Drive Heel Incision Devices Market

Premature babies, especially those born very early, often have complicated medical issues. Typically, complications of prematurity vary; however, earlier the baby is born, the higher the risk of complications. Therefore, dozens of new tests are presently available, which can offer insights into the health condition of newborns. High birth rate of preterm babies leads to complications and even to death of babies within one month of birth, which is a global concern, especially in underdeveloped and developing countries of Africa and South Asia. Consequently, several countries, such as the U.S., Australia, Germany, and the U.K., have introduced numerous health policies under which newborn screening is mandatory, which, in turn, propels the heel incision devices market.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79383

Products for Newborns to Dominate Heel Incision Devices Market

In terms of product type, the global heel incision devices market has been classified into micro-preemie, preemie, newborn, and infant. Doctors prefer to screen newborns within the first 1 to 2 days after birth to diagnosis diseases, as it takes that long for abnormal levels to show up in the blood, and this is likely to fuel the segment.

Hospitals & Specialty Clinics to be Highly Attractive End User

In terms of end user, the heel incision devices market has been divided into hospitals & specialty clinics, ambulatory surgical centers, and others. The high preference for hospitals & nursing homes due to availability of all levels of treatment, reimbursement facilities, and rise in awareness about different treatment support provided in hospitals are key factors driving the segment.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=79383

North America to Dominate Heel Incision Devices Market

The global heel incision devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global heel incision devices market in 2019, followed by Europe. North America accounted for a major share of the global heel incision devices market in 2019, primarily due to well-established healthcare infrastructure that enables proper diagnosis. Moreover, a rise in awareness about newborn screening in the U.S. drives the demand for heel incision devices.

Heel Incision Devices Market: Competition Landscape

The global heel incision devices market is fragmented in terms of number of players. Key players in the global surgical equipment market include BD, Owen Mumford Ltd., Cardinal Health, Smiths Medical, Clinical Innovations, LLC, MediCore, Vitrex Medical A/S, NSP Medicals, and Torvan Medical Inc.

Read Report Overview: https://www.transparencymarketresearch.com/heel-incision-devices-market.html

Global Heel Incision Devices Market: Segmentation

Heel Incision Devices Market, by Product Type
Micro-preemie,
Preemie
Newborn
Infant

Heel Incision Devices Market, by End User
Hospitals & Specialty Clinics
Ambulatory Surgical Centers
Others

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=79383

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.